Table 2.
Characteristics of radiologic imaging and pathology in patients with IPMN with/without AP
| IPMN | P-value | ||
|---|---|---|---|
| AP (n = 11) | Non-AP (n = 36) | ||
| Radiologic imaging | |||
| IPMN Site | 1.000 | ||
| Body and tail | 2 (18.2) | 6 (16.7) | |
| Head and neck | 9 (81.8) | 30 (83.3) | |
| IPMN type | 0.785 | ||
| MD | 1 (9.1) | 4 (11.1) | |
| MIX | 3 (27.3) | 14 (38.9) | |
| BD | 7 (63.6) | 18 (50.0) | |
| MPD | 0.435 | ||
| < 10 mm | 7 (63.6) | 28 (77.8) | |
| ≥ 10 mm | 4 (36.4) | 8 (22.2) | |
| Cystic | |||
| < 30 mm | 7 (63.6) | 13 (38.2) | 0.176 |
| ≥ 30 mm | 4 (36.4) | 21 (61.8) | |
| missing | 0 | 2 | |
| Tuberous enhancement | 3 (27.3) | 8 (22.2) | 0.703 |
| Cystic wall enhancement | 3 (27.3) | 13 (36.1) | 0.725 |
| Calcification | 3 (27.3) | 4 (11.1) | 0.330 |
| Pathology | |||
| Epithelial subtype | 0.494 | ||
| Gastric | 0 (0) | 6 (21.4) | |
| Intestinal | 3 (42.9) | 6 (21.4) | |
| Pancreatobiliary | 3 (42.9) | 13 (46.4) | |
| Oncocytic | 1 (14.3) | 3 (10.7) | |
| Unknown | 4 | 8 | |
| Degree of dysplasia | 0.213 | ||
| LGD | 2 (18.2) | 11 (30.6) | |
| MGD | 3 (27.3) | 14 (38.9) | |
| HGD | 4 (36.4) | 3 (8.3) | |
| IC | 2 (18.2) | 8 (22.2) | |
| Chronic pancreatitis | 3 (27.3) | 14 (38.9) | 0.722 |
| Glandular atrophy | 2 (18.2) | 8 (22.2) | 1.000 |
AP: acute pancreatitis; BD: branch duct subtype; HGD: high grade dysplasia; IC: invasive cancer; IPMN: intraductal papillary mucinous neoplasms; LGD: low grade dysplasia; MD: main duct subtype; MIX: mixed type; MGD: moderate grade dysplasia; MPD: main pancreatic duct
Continuous data are presented as median (Q1-Q3) and categorical data are presented as n (%)